DOCSLIB.ORG

STOXX Changes Composition of Strategy Indices Effective on March 22Nd, 2021

Total Page：16

File Type：pdf, Size：1020Kb

Download full-text PDF Read full-text
STOXX Changes Composition of Strategy Indices Effective on March 22Nd, 2021 Zug, March 13th, 2021 STOXX Changes composition of Strategy Indices effective on March 22nd, 2021 Dear Sir and Madam, STOXX Ltd., the operator of Qontigo’s index business and a global provider of innovative and tradable index concepts, today announced the new composition of STOXX Strategy Indices as part of the regular quarterly review effective on March 22nd, 2021 Date Symbol Index name Internal Key ISIN Company name Changes 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW01UK TW0001722007 Twn Fertilizer Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD CN0010 CNE1000002H1 CHINA CONSTRUCTION BANK CORP H Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW02MD TW0002301009 Liteon Tech Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD CN249E CNE000000T59 YANTAI CHANGYU PION.WINE 'B' Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD CN1I6O CNE100000HF9 CHINA MINSHENG BANKING H Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW025W TW0002015005 Feng Hsin Iron Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW505Z TW0006412000 CHICONY POWER TECHNOLOGY Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW0751 TW0004938006 Pegatron Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD 691316 HK0270001396 Guangdong Investment Ltd. Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW40C5 TW0008150004 CHIPMOS TECHNOLOGIES Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW0593 TW0002855004 President Sec Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD CN40IL CNE100001QW3 CHINA EVERBRIGHT BK.'H' Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TH21Q3 TH0209010Z07 THAI VEGETABLE OIL Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD B0D000 TREBIMM00018 BIM BIRLESIK MAGAZALAR Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD CN31JM CNE100001NV2 SINOPEC ENGR.(GP.) 'H' Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TH90AT TH8351010005 CPN RETAIL GROWTH LEASE REIT Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD 635425 BMG2442N1048 COSCO SHIPPING PORTS Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD KR01MY KR7001450006 Hyundai Mar&Fire Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD 431519 TRAEREGL91G3 EREGLI DEMIR CELIK Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW10UK TW0006213002 ITEQ Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD PH047H PHY0005M1090 Aboitiz Power Corp Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD EV052 RU000A0JPNN9 FED.GRID CO.OF UNG.SY. Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD EV050 RU000A0JKQU8 MAGNIT Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD EV005 RU000A0JPKH7 RUSHYDRO Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD CN31IL CNE100001NT6 CHINA GALAXY SECURITIES 'H' Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD MY104P MYL4677OO000 YTL Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD EV060 RU000A0JPNM1 INTER RAO UES Addition 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD EV010 RU000A0JNAA8 POLYUS Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD EV007 RU000A0JP7J7 PIK GRP Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD 715033 RU0007775219 MTS Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD MY009T MYL6012OO008 Maxis Bhd Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TH007H TH0268010Z03 ADVANCED INFO SERVICE PCL Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD VN003L VN000000FPT1 FPT Corp Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD CN1ABL CNE100000585 TONG REN TANG TECHS.'H' Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD IN01BH INE079A01024 Ambuja Cem Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD IN02Z6 INE486A01013 CESC Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD IN07R3 INE848E01016 NHPC Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD IN07ZB INE881D01027 Oracle Fin Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW01A0 TW0001409001 Shinkong Syn Fib Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW01G6 TW0001504009 Teco Electric Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW040T TW0002474004 Catcher Tech Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW05JD TW0002903002 Far East Dept Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW05KE TW0002912003 President Chain Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TW05UO TW0003026001 Holystone Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD CN1IBT CNE100000X85 ZOOMLION HDY.SCTC. 'H' Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD EG2051 EGS37091C013 EASTERN TOBACCO Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TH21P2 TH0201A10Y01 INTOUCH HOLDINGS Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD MY22ZN MYL4162OO003 BRIT.AMER.TOB.(MALAYSIA) Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD MY23AZ MYL5211OO007 SUNWAY Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD PK20S3 PK0081801018 PAKISTAN PETROLEUM Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD PK211D PK0012101017 ENGRO Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD CN247C CNE000000SK7 INNER MONGOLIA YITAI COAL 'B' Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD TH403H TH4577010002 MK RESTAURANT GROUP Deletion 12.03.2021 EDEDSL STOXX Emerging Markets Diversification Select 100 USD CN57U5 CNE100001ZT0 LEGEND HOLDINGS 'H' Deletion 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR TW1AKK TW0006214000 SYSTEX Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR TW01UK TW0001722007 Twn Fertilizer Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR HK01SU HK1883037637 CITIC TELECOM INT L HOLDINGS Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR CN0010 CNE1000002H1 CHINA CONSTRUCTION BANK CORP H Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR CN1I6O CNE100000HF9 CHINA MINSHENG BANKING H Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR TW025W TW0002015005 Feng Hsin Iron Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR TW505Z TW0006412000 CHICONY POWER TECHNOLOGY Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR PK303F PK0085101019 HABIB BANK Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR TW40C5 TW0008150004 CHIPMOS TECHNOLOGIES Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR TW0593 TW0002855004 President Sec Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR B0D000 TREBIMM00018 BIM BIRLESIK MAGAZALAR Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR CN31JM CNE100001NV2 SINOPEC ENGR.(GP.) 'H' Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR 635425 BMG2442N1048 COSCO SHIPPING PORTS Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR TH90AT TH8351010005 CPN RETAIL GROWTH LEASE REIT Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR 431519 TRAEREGL91G3 EREGLI DEMIR CELIK Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR EV052 RU000A0JPNN9 FED.GRID CO.OF UNG.SY. Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR EV005 RU000A0JPKH7 RUSHYDRO Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR TW10UK TW0006213002 ITEQ Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR EV060 RU000A0JPNM1 INTER RAO UES Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR CN31IL CNE100001NT6 CHINA GALAXY SECURITIES 'H' Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR MY104P MYL4677OO000 YTL Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR 405180 TRAARCLK91H5 ARCELIK Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR CN0OH4 CNE100000221 BEIJING CAP.INTL.ARPT. 'H' Addition 12.03.2021 EDEDSP STOXX Emerging Markets Diversification Select 100 EUR RU501R RU0007252813
Load more

Recommended publications
  • Master Thesis Master's Programme in Industrial Management and Innovation, 120 Credits
    Master Thesis Master's Programme in Industrial Management and Innovation, 120 credits Capturing Business Model Innovation Driven by the Emergence of New Technologies in Established Firms A Case Study at Siemens Healthineers Thesis in Industrial Innovation Management, 30 credits Halmstad 2018-06-16 Emma Bäckman, Josefin Ellmarker HALMSTAD UNIVERSITY Abstract Background: It is argued that the emergence of new technologies and the digitalization can improve the healthcare, make it more efficient, personalized and available for everyone. The healthcare has already begun to become more digitized and there is no doubt that this trend will continue. Moreover, it is argued that AI will have a major impact on the MedTech and healthcare industry. Problem discussion: To stay competitive it has been concluded that firms must update and rethink their business models constantly thus, to undertake business model innovation. This applies specially to established firms that have been successful with the same business model for a long time. Despite the fact that the existing literature addresses the importance of business model innovation, very little attention has been drawn to how to actually achieve this change. Purpose: The purpose of this study is to explore how business models in established firms within the MedTech industry develops over time due to the emergence of new technologies. More specifically, we focus on how artificial intelligence is influencing and will influence the business models in the MedTech industry. Methodology: This study has been performed through a single case study at Siemens Healthineers. The primary data has been gathered through four meetings with people with expertise in the field of artificial intelligence as well as the MedTech and healthcare industry.
    [Show full text]
  • Liberty Latin America Completes Split-Off from Liberty Global
    Liberty Latin America Completes Split-Off from Liberty Global Newly listed company well-positioned to leverage world-class technology, innovation and scale Value creation strategy to stem from both organic and inorganic opportunities Denver, Colorado – January 2, 2018 Liberty Latin America Ltd. (NASDAQ: LILA and LILAK, OTC Link: LILAB) (“Liberty Latin America”), a leading telecommunications company with operations in Chile, Puerto Rico, the Caribbean and other parts of Latin America, today announced the completion of its previously announced split-off from Liberty Global plc (“Liberty Global”) and its launch as an independent, publicly-traded company. Following the successful completion of the split-off, Liberty Latin America Class A and Class C common shares are now trading on the NASDAQ Global Select Market under the symbols “LILA” and “LILAK,” respectively, and the Class B common shares are quoted on the OTC Markets under the symbol “LILAB”. Mike Fries, Executive Chairman of Liberty Latin America and CEO of Liberty Global, commented, “The split-off of our Latin American and Caribbean operations from Liberty Global will ensure that this new company will have access to the capital and resources necessary to achieve superior financial and strategic growth. I have tremendous confidence in Balan Nair’s leadership as well as the world-class board of directors and management team we have put in place. As Liberty Latin America charts its own course going forward, it will continue to benefit from its Liberty Global heritage and will have access to key shared services and expertise across products, technology, procurement and more. The launch of Liberty Latin America is an exciting moment for all shareholders and a clear confirmation of the opportunity for value creation in the Latin American and Caribbean region.” Balan Nair, President and Chief Executive Officer of Liberty Latin America, stated, “Today marks an important milestone for Liberty Latin America as we begin the path forward as an independent company focused squarely on the region.
    [Show full text]
  • BGP Interconnection in the Region of Latin America and the Caribbean
    BGP Interconnection in the Region of Latin America and the Caribbean Author: Augusto Mathurín Coordination/Revision: Guillermo Cicileo Edition and Design: Maria Gayo, Carolina Badano, Martín Mañana Project: Strengthening Regional Internet Infrastructure Department: Internet Infrastructure R&D Contents Contents 2 Introduction 4 Methodology 4 Stated Objectives 4 Data Sources 4 Data Processing 6 Generated Datasets 8 Data by Country 10 Argentina 10 Aruba 12 Bolivia 13 Brazil 15 Belize 17 Chile 19 Colombia 21 Costa Rica 23 Cuba 25 Dominican Republic 27 Ecuador 29 French Guiana 31 Guatemala 32 Guyana 34 Honduras 36 Haiti 38 Mexico 40 Nicaragua 42 Panama 44 2 Peru 46 Paraguay 48 Suriname 50 El Salvador 52 Trinidad and Tobago 54 Uruguay 56 Venezuela 58 Regional Data Analysis 60 Connection to the Other Regions 62 Conclusions and Future Work 65 3 Introduction Internet development and the quality of user connectivity depend on the existence of good communications infrastructure and proper connectivity between countries. In Latin America, there are still some deficiencies in this regard which result in many people experiencing high latencies in their connections. The main reason for these latencies is the lack of local interconnection between different network operators, which means that traffic between nearby countries must often use distant Internet exchange points, located in the United States or Europe. The deployment of various Internet exchange points (IXPs) has helped improve this situation, although the actual status of connectivity between countries and networks remains a mystery. To find answers to these unknowns, some time ago LACNIC created Simón1, a project that seeks to generate information by measuring latency levels between countries and in this way estimate traffic volumes.
    [Show full text]
  • Medical Additive Manufacturing/ 3D Printing Annual Report 2018 Improving Public Health
    Medical Additive Manufacturing/ 3D Printing Annual Report 2018 Improving Public Health Each year, healthcare needs and costs grow due to an aging population, the rise in chronic diseases, and more. In fact, global healthcare spending is projected to reach nearly $9 trillion by 20201. To address this, practitioners in the healthcare industry continue to look for innovations that can provide quality care to patients at a reasonable cost. But they can’t do it alone. Today, the manufacturing industry is an important partner, with one particularly bright opportunity focused on Medical Additive Manufacturing/3D Printing (AM3DP). From anatomical models to early bioprinting applications, the use of AM3DP is providing benefits for patients and physicians/institutions including: ■ Better patient outcomes ■ Less time in the operating room ■ Reduced costs In 2017, as outlined in this Annual Report, collaboration between hospitals, device manufacturers, U.S. Food and Drug Administration (FDA), and partners such as SME, led to extraordinary strides in identifying industry trends, opportunities, challenges and solutions. These partnerships drive efficiency through best practice sharing as well as accelerate innovation for applications such as bioprinting and tissue fabrication. They also lay the groundwork for 3D printing of organs and scaling up production of tissues which are still decades away. With millions of patients already directly impacted by the technology, this momentum continues into 2018 and beyond where AM3DP will continue to positively impact public health and drive strong business results. This 2017 Annual Report covers: COVER: Justin Ryan holds a pediatric heart model 3D-printed at the ■ Industry Overview Phoenix Children’s Hospital Cardiac 3D Print Lab.
    [Show full text]
  • Healthcare & Life Sciences Group
    HEALTHCARE & LIFE SCIENCES GROUP 2 1 Healthcare and life sciences clients have long turned to S&C for help succeeding in today’s rapidly changing business environment. Large and mid-size, public and private, throughout their lifecycles, these companies rely on our multi-disciplinary, global team to address their most complex legal and business challenges and reach their strategic goals. Sector expertise: We offer unrivaled OUR CLIENTS GET… knowledge of the healthcare and life sciences industries, our clients’ businesses and the sector-specific competitive pressures bearing down on them. Sullivan & Cromwell’s Healthcare and Life Sciences Group has negotiated complex transactions and resolved high-stakes disputes for almost three decades. Today, it possesses an unparalleled grasp of these sectors and a practical understanding of the commercial realities underlying them. We position our clients to succeed through it all. The Firm represents international clients in the following healthcare sectors: Pharmaceuticals and Life Sciences Medtech Health Insurers Healthcare Services 2 Legal expertise: Clients come to us An integrated, global team: for the high-quality counsel and hands-on We’re a core group of dedicated healthcare representation we offer across multiple advisers across our 13 offices on four legal specialties, to successfully execute continents with a strong track record of their most important deals and resolve the sector’s most significant transactions critical disputes. We can execute any type and litigation matters, supported by all of transaction in any economic climate or the resources of an integrated, global firm. geographic region. Our experience in this We’re grateful to our clients for trusting sector includes: us with their future, and we’ll continue to help them position themselves for growth M&A and success in this exciting and ever- Corporate finance changing industry.
    [Show full text]
  • Conference Programme Speakers Overview
    CONFERENCE BOOK Celebrating 60 years of the benefits of innovation in medical technology to Society CONFERENCE PROGRAMME & SPEAKERS OVERVIEW 13 & 14 NOVEMBER 2019 COCIR, the European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry European Coordination Committee of the Radiological, Electromedical and Healthcare IT Industry PROGRAM WEDNESDAY 13 NOVEMBER 2019 17:30 REGISTRATION & WELCOME Drinks, Photographs 18:30 ANNIVERSARY CEREMONY OPENING BY COCIR PRESIDENT Jan KIMPEN / COCIR President and Chief Medical Officer at Royal Philips KEYNOTE SPEECHES BY EUROPEAN COMMISSION Manuel MATEO GOYET / Member of the Cabinet of Commissioner Gabriel, the Digital Economy and Society portfolio at the European Commission Andrzej RYS / Director Health Systems, Medical Products & Innovation at DG Santé, European Commission HEALTHCARE FUTUROLOGIST: “WHAT DOES THE FUTURE HOLD?” Koen KAS / Healthcare futurist, entrepreneur, professor of molecular oncology, and renowned international keynote speaker. 19:30 GALA DINNER Museum visit (optional) & Networking 2 COCIR 60 YEARS ANNIVERSARY COCIR PROGRAM PROGRAM THURSDAY 14 NOVEMBER 2019 08:30 REGISTRATION & WELCOME / Coffee 09:00 WELCOME by Nicole DENJOY / COCIR Secretary General Moderation by Maryline FIASCHI / Managing Director, Science Business 09:15 KEYNOTE SPEECH BY FINNISH PRESIDENCY Tuula HELANDER / Senior Advisor, Cabinet and Strategy Group of the Permanent Secretary, Ministry of Social Affairs and Health, Health Secretary General, Finnish Cancer Institute 09:30 SESSION
    [Show full text]
  • Vtr Finance Bv
    VTR FINANCE B.V. Annual Report December 31, 2018 VTR FINANCE B.V. Boeing Avenue 53 1119 PE Schiphol-Rijk The Netherlands VTR FINANCE B.V. TABLE OF CONTENTS Page Number Forward-looking Statements 2 Business 4 Management and Governance 13 Independent Auditors’ Report 15 Consolidated Balance Sheets as of December 31, 2018 and 2017 16 Consolidated Statements of Operations for the Years Ended December 31, 2018, 2017 and 2016 18 Consolidated Statements of Comprehensive Earnings (Loss) for the Years Ended December 31, 2018, 2017 and 2016 19 Consolidated Statements of Owner’s Deficit for the Years Ended December 31, 2018, 2017 and 2016 20 Consolidated Statements of Cash Flows for the Years Ended December 31, 2018, 2017 and 2016 21 Notes to Consolidated Financial Statements 23 Management’s Discussion and Analysis of Financial Condition and Results of Operations 46 1 FORWARD-LOOKING STATEMENTS Certain statements in this annual report constitute forward-looking statements. To the extent that statements in this annual report are not recitations of historical fact, such statements constitute forward-looking statements, which, by definition, involve risks and uncertainties that could cause actual results to differ materially from those expressed or implied by such statements. In particular, statements under Business and Management’s Discussion and Analysis of Financial Condition and Results of Operations may contain forward-looking statements, including our business, product, service offering, foreign currency and finance strategies in 2019; our property
    [Show full text]
  • Common Stocks — 104.5%
    Eaton Vance Tax-Advantaged Global Dividend Income Fund January 31, 2021 PORTFOLIO OF INVESTMENTS (Unaudited) Common Stocks — 104.5% Security Shares Value Aerospace & Defense — 0.8% Safran S.A.(1) 98,721 $ 12,409,977 $ 12,409,977 Banks — 6.7% Bank of New York Mellon Corp. (The) 518,654 $ 20,657,989 Citigroup, Inc. 301,884 17,506,253 HDFC Bank, Ltd.(1) 512,073 9,775,702 ING Groep NV(1) 1,676,061 14,902,461 Japan Post Bank Co., Ltd. 445,438 3,851,696 Mitsubishi UFJ Financial Group, Inc. 2,506,237 11,317,609 Mizuho Financial Group, Inc. 292,522 3,856,120 Sumitomo Mitsui Financial Group, Inc. 186,747 5,801,916 Wells Fargo & Co. 341,979 10,218,332 $ 97,888,078 Beverages — 1.0% Diageo PLC 378,117 $ 15,180,328 $ 15,180,328 Biotechnology — 1.2% CSL, Ltd. 82,845 $ 17,175,550 $ 17,175,550 Building Products — 0.9% Assa Abloy AB, Class B 509,607 $ 12,603,485 $ 12,603,485 Chemicals — 0.7% Sika AG 38,393 $ 10,447,185 $ 10,447,185 Construction & Engineering — 0.0% Abengoa S.A., Class A(1)(2) 311,491 $ 0 Abengoa S.A., Class B(1)(2) 3,220,895 0 $0 Construction Materials — 0.9% CRH PLC 332,889 $ 13,660,033 $ 13,660,033 Consumer Finance — 0.6% Capital One Financial Corp. 79,722 $ 8,311,816 $ 8,311,816 1 Security Shares Value Diversified Financial Services — 2.5% Berkshire Hathaway, Inc., Class B(1) 101,853 $ 23,209,243 ORIX Corp.
    [Show full text]
  • Siemens Annual Report 2018
    Annual Report 2018 siemens.com Table of contents . A B C Combined Management Report Consolidated Financial Statements Additional Information A.1 p 2 B.1 p 62 C.1 p 132 Organization of the Siemens Group Consolidated Statements Responsibility Statement and basis of presentation of Income C.2 p 133 A.2 p 3 B.2 p 63 Independent Auditor ʼs Report Financial performance system Consolidated Statements of Comprehensive Income C.3 p 139 A.3 p 6 Report of the Supervisory Board Segment information B.3 p 64 Consolidated Statements C.4 p 144 A.4 p 18 of Financial Position Corporate Governance Results of operations B.4 p 65 C.5 p 157 A.5 p 21 Consolidated Statements Notes and forward- looking Net assets position of Cash Flows statements B.5 p 66 A.6 p 22 Financial position Consolidated Statements of Changes in Equity A.7 p 26 B.6 p 68 Overall assessment of the economic position Notes to Consolidated Financial ­Statements A.8 p 28 Report on expected developments and associated material opportunities and risks A.9 p 40 Siemens AG A.10 p 43 Compensation Report A.11 p 57 Takeover-relevant information A. Combined Management Report A.1 Organization of the Siemens Group and basis of pr esentation Siemens is a technology company with core activities in the fields Non-financial matters of the Group of electrification, automation and digitalization and activities and Siemens AG in nearly all countries of the world. We are a leading supplier of Siemens has policies for environmental, employee and social power generation, power transmission and infrastructure solu- matters, for the respect of human rights, and anti-corruption and tions as well as automation, drive and software solutions for in- bribery matters, among others.
    [Show full text]
  • Siemens Healthineers · Flyer DIN Long Portrait · Template
    Dr. Roland Busch Information on the Supervisory Board candidate proposed for election under Agenda Item 6 2002 Siemens Aktiengesellschaft, Head of Memberships of comparable domestic or Infotainment Solutions Division foreign controlling bodies of commercial enterprises: 2005 Siemens VDO Automotive Asia Pacific Co. Ltd., Shanghai, China • Atos SE, Bezons, France • President and CEO • Arabia Electric Ltd. (Equipment), Jeddah, * 2007 Siemens Aktiengesellschaft, Saudi Arabia Transportation Systems Group, • ESMT European School of Management Erlangen, Germany and Technology GmbH, Berlin, Germany • Head of Mass Transit Division Dr. Roland Busch • ISCOSA Industries and Maintenance Ltd., * 2008 Siemens Aktiengesellschaft, Dammam, Saudi Arabia (deputy chairman) Deputy Chief Executive Officer, Chief Corporate Development Department, • Siemens Ltd., Riyadh, Saudi Arabia* Technology Officer and member of the Munich, Germany Managing Board of Siemens Aktien­ • Siemens W.L.L., Doha, Qatar* gesellschaft, Berlin and Munich, Germany • Head of Corporate Strategies • VA TECH T&D Co. Ltd., Riyadh, born on November 22, 1964 in Erlangen, 2011 Member of the Managing Board of Saudi Arabia* Siemens Aktiengesellschaft Germany • Chief Technology Officer since Dr. Busch is a member of the Managing December 2016 Education: Board of Siemens Aktiengesellschaft, with its • Chief Operating Officer from registered seat in Berlin and Munich. Siemens October 2018 until September 2019 • Studied physics at Friedrich Alexander since Aktiengesellschaft directly and indirectly University in Erlangen­Nuremberg, Germany, 2019 • Chairman of the Supervisory Board holds 85% of the Company’s capital stock at and at the University of Grenoble, France of Siemens Mobility GmbH since the time Notice of the Annual Shareholders’ Meeting is given. Pursuant to Section 5.4.1 (6) • Dipl.­Phys., Dr.
    [Show full text]
  • Life Sciences Newsletter Q2 2018
    KPMG Corporate Finance LLC Healthcare Life Sciences M&AQuarterly Q2 2018 © 2018 KPMG Corporate Finance LLC, a Delaware limited liability company. Member FINRA and SIPC. KPMG Corporate Finance LLC is a subsidiary of KPMG LLP, a Delaware limited liability partnership and the U.S. member firm of the KPMG network of independent member firms affiliated with KPMG International Cooperative (“KPMG International”), a Swiss entity. All rights reserved. LIFE SCIENCES M&A NEWSLETTER KPMG Corporate Finance LLC Global Life Sciences Sector Coverage(1) U.S. Life Sciences Team Jason Moran Amanda Dydynski Erik Jordan Sandy Prabhakar Managing Director & Head Senior Associate Director & Head of Director & Head of of Healthcare Life Sciences Healthcare Life Sciences Private Equity International Desk San Francisco San Francisco Los Angeles Chicago T: 415-949-8909 T: 415-963-8401 T: 213-955-8722 T: 312-665-1990 E: [email protected] E: [email protected] E: [email protected] E: [email protected] United Kingdom Germany France Canada Japan Andrew Nicholson Florian Frei Guillaume Cauchoix Neil Blair Toshiaki Ishii Ireland Sweden Spain India China Michele Connolly Christian Terslow Luis Zaragoza Sanjay Singh Andy Qiu Finland Switzerland Italy South Korea Australia Jukka Teikari Patrik Kerler Paulo Mascaretti Sung-Won Park Peter Turner Netherlands Austria Portugal Vietnam New Zealand Danny Bosker Klaus Mittermair João Leal John Ditty Gary Ivory Denmark Belgium Poland Russia Philippines Eric Bots-Bjerre Peter Lauwers Krzysztof Klamut Robert Vartevanian Michael Guarin KPMG Corporate Finance(1) KPMG Corporate Finance provides a broad range of investment banking and strategic advisory services to domestic and international clients and is a leading global middle market investment banking platform — Average 350 transactions annually for the last five years — Over 2,500 investment banking professionals worldwide — Offices in 84 countries with extensive cross-border abilities Notes: (1) Represents the global Corporate Finance practices of KPMG International’s network of independent member firms.
    [Show full text]
  • Ready Awarded It to Operators by the End of 2016, Whereas Mexico Has Already Allocated 90 Mhz of That Band to Those in Charge of Deploying the Shared Network
    TABLE OF CONTENTS TABLE OF CONTENTS ............................................................................................................ 2 EXECUTIVE SUMMARY ........................................................................................................... 3 INTRODUCTION ...................................................................................................................... 6 ITU MOBILE SPECTRUM SUGGESTIONS .............................................................................. 8 ITU RECOMMENDATIONS: SPECTRUM ALLOCATION FOR THE DEVELOPMENT OF IMT AND IMT-ADVANCED TECHNOLOGIES .............................................................................. 9 LATIN AMERICA SPECTRUM OVERVIEW ............................................................................ 10 FUTURE OF THE RADIO SPECTRUM IN LATIN AMERICA ................................................... 12 CHALLENGES TO AWARD THE RADIO SPECTRUM ............................................................ 15 CONCLUSION ........................................................................................................................ 16 APPENDIX A: LATIN AMERICA MARKETS PROFILES ......................................................... 18 ARGENTINA ....................................................................................................................... 18 BOLIVIA ............................................................................................................................. 18 BRAZIL ..............................................................................................................................
    [Show full text]